Also it's a bit early to be saying 534 works since they have only done a phase 1 trial!
There is no question that the drug works and works well - read the ASCO presentations for yourself if you don't believe me. What still remains to be seen is whether it can move up from 3rd line over time or not.
Market Data 
Markets 
AI
